Energy expenditure, energy intake and prevalence of obesity after therapy for acute lymphoblastic leukemia during childhood

Hormone Research

Volumn 53, Issue 4, 2000, Pages 193-199

  Mayer, Eleonore I E ^a,b   Reuter, Marianne ^a   Dopfer, Roland E ^a   Ranke, Michael B ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b NONE   (Germany)

Author keywords

Caloric intake; Children; Malignancy; Metabolic rate; Physical activity; Weight

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; HORMONE; HYDROCORTISONE; LEPTIN; METHOTREXATE; SOMATOMEDIN BINDING PROTEIN 3; TESTOSTERONE; THYROXINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CANCER COMBINATION CHEMOTHERAPY; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; ENERGY EXPENDITURE; FEMALE; HUMAN; MALE; METABOLIC RATE; OBESITY; PATHOGENESIS; PHYSICAL ACTIVITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SKULL IRRADIATION;

EID: 0033764872     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023566     Document Type: Article

References (25)

1. Weight gain and height velocity during prolonged first remission from acute lymphoblastic leukaemia
2. Growth, puberty and obesity after treatment for leukaemia
3. High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia in childhood
4. Influence of treatment modalities on body weight in acute lymphoblastic leukemia
5. Patterns of obesity in boys and girls after treatment for acute lymphoblastic leukaemia
6. A method of predicting adult height and obesity in long-term survivors of childhood acute lymphoblastic leukaemia
7. Obesity after sucessful treatment of acute lymphoblastic leukemia in childhood
8. Prevalence of obesity in children after therapy for acute lymphoblastic leukemia
9. Schadelbestrahlung als Ursache fur Adipositas nach ALL-Therapie im Kindesalter
10. Therapiestudie BFM 79/81 zur Behandlung der akuten lymphoblastischen Leukamie bei Kindern und Jugendlichen: Intensivierte Reinduktionstherapie fur Patientengruppen mit unterschiedlichem Rezidivrisiko
11. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86
12. Die Corticoisteroid-abhangige Dezimierung der Leukamiezellzahl im Blut als Prognosefaktor bei der akuten lymphoblastischen Leukamie im Kindesalter (Therapiestudie ALL-BFM 83)
13. Konzeption und Zwischenergebnis der Therapiestudie ALL-BFM 90 zur Behandlung der akuten lymphoblastischen Leukamie bei Kindern und Jugendlichen: Die Bedeutung des initialen Therapieansprechens in Blut und Knochenmark
14. Energy requirements and dietary energy recommendations for children and adolescents 1 to 18 years old
15. Body mass index variations: Centiles from birth to 87 years
16. Radioimmunoassays for IGFs and IGFBPs
17. Plasma leptin levels in healthy children and adolescents: Dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone
18. Resting metabolic rate and obesity in childhood acute lymphoblastic leukaemia
19. Daily energy expenditure and physical activity in survivors of childhood malignancy
20. Metabolic predictors of obesity. Contribution of resting energy expenditure, thermic effect of food, and fuel utilization to four-year weight gain of post-obese and never-obese women
21. Lung function and exercise capacity in survivors of childhood leukaemia
22. Comparison of dietary assessment methods in nutritional epidemiology: Weighed records vs. 24 h recalls, food-frequency questionnaires and estimated-diet records
23. A novel variant of growth hormone (GH) insufficiency following low dose cranial irradiation
24. Discontinuing growth hormone and early metabolic effects
25. Body composition and energy expenditure in thyroidectomized patients during short-term hypothyroidism and thyrotropin-suppressive thyroxine therapy